BetterLife Pharma (FRA:NPAU) Common Stock: €51.34 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:NPAU BetterLife Pharma Inc FRA:NPAU
37 GF Score
Price €0.12
! 2 Warning Signs
View Full Analysis

What is BetterLife Pharma Common Stock?

BetterLife Pharma FRA:NPAU -13.24% 37 Common Stock is €51.34 Mil as of Apr. 2026. GuruFocus rates FRA:NPAU with a GF Score™ of 37/100. The stock has 2 warning signs investors should review.

BetterLife Pharma's quarterly common stock increased from Oct. 2025 (€50.33 Mil) to Jan. 2026 (€50.65 Mil) and increased from Jan. 2026 (€50.65 Mil) to Apr. 2026 (€51.34 Mil).

BetterLife Pharma's annual common stock increased from Jan. 2024 (€53.66 Mil) to Jan. 2025 (€53.68 Mil) but then declined from Jan. 2025 (€53.68 Mil) to Jan. 2026 (€50.65 Mil).

BetterLife Pharma Common Stock Historical Data

* Premium members only.

The historical data trend for BetterLife Pharma's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BetterLife Pharma Common Stock Chart

BetterLife Pharma Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 52.80 52.94 53.66 53.68 50.65

BetterLife Pharma Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51.82 51.30 50.33 50.65 51.34
FRA:NPAU
37GF Score
BetterLife Pharma Inc FRA:NPAU
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BetterLife Pharma Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €51.34 Mil mean?
BetterLife Pharma (FRA:NPAU) has a Common Stock of €51.34 Mil as of Apr. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on BetterLife Pharma and its competitors.
Is BetterLife Pharma's Common Stock too high?
BetterLife Pharma's current Common Stock is €51.34 Mil. Overall, BetterLife Pharma has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does BetterLife Pharma's Common Stock compare to VRTX and REGN?
BetterLife Pharma's Common Stock of €51.34 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on BetterLife Pharma and its competitors. BetterLife Pharma's current Common Stock is €51.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BetterLife Pharma stock overvalued right now?
BetterLife Pharma (FRA:NPAU) has a current Common Stock of €51.34 Mil. The current Common Stock is €51.34 Mil. BetterLife Pharma's overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For BetterLife Pharma (FRA:NPAU), the current Common Stock is €51.34 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BetterLife Pharma Business Description

Address 1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc is a biopharmaceutical company engaged in the development of patented pharmaceuticals. It is an emerging biotechnology company mainly focused on developing compounds for the treatment of mental disorders. It is also refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight viral infections. The Company operates in one industry segment, development and commercialization of patented pharmaceuticals within one geographical area.
37GF Score

Get the complete analysis for FRA:NPAU

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.12
Price